Report cover image

Fill Finish Catridge Market: Current Analysis and Forecast (2022-2028)

Publisher UnivDatos Market Insights
Published Feb 01, 2023
Length 158 Pages
SKU # Univ17823865

Description

Fill Finish Catridge Market: Current Analysis and Forecast (2022-2028)

Fill finish cartridge is a process of introducing the drug product into the cartridge under aseptic conditions, which is critical to ensure the safety and efficacy of the product. The market for fill finish cartridges is growing at a tremendous rate owing to the rising number of pharmaceutical companies and the surge in the demand for biologics drugs in the management of diabetes, and other chronic diseases. Moreover, the rising penetration of contract manufacturing organizations (CMO) in various biotech companies is also considered a significant factor in driving the market growth.

The Fill Finish Cartridge Market is expected to grow at a steady rate of around 9.7% owing to a surge in the prevalence of diabetes. According to the data from the International Diabetes Federation 2021 report, the prevalence of type 2 diabetes was around 405.6 million, which is projected to increase to approximately 510.8 million by 2030. Moreover, as per the CDC, approximately 37.3 million people in the U.S. had diabetes in 2020, with 28.7 million diagnosed and 8.5 million undiagnosed cases. Furthermore, about 96 million people aged 18 years and older have prediabetes. Thus, the surge in the prevalence of diabetes will have a positive impact on the growth of the market during the forecast period.
  • Based on cartridge size, the market is segmented into less than 1 ml, 1ml-3ml, and more than 3ml. The 1ml-3ml category held the dominant share in the market in 2021. This is mainly due to the surge in the incidences of diabetes, the rising affordability of insulin cartridges, advancements in drug delivery systems, and the growing awareness regarding the treatment of the disease.
  • On the basis of drug type, the market is bifurcated into biologics and others. The others segment, including dental anesthesia, is expected to grow with a high CAGR during the forecast period as a result of rising disposable income and increasing oral awareness. Apart from this, countries such as China and India are currently the greatest producers and consumers of tobacco with the lowest awareness levels about smoking hazards. These are the elements that are anticipated to fuel the market during the forecast period.
  • On the basis of injection devices, the market is bifurcated into pens and autoinjectors. The pens held the dominant share in the market in 2021. The most common insulin administration tools used by diabetic patients, particularly in industrialized nations, are insulin pens. Insulin pens are widely used by insulin users due to their simplicity of use and precision in delivery. Moreover, rising technological advancements is also driving the adoption of pens in the global market. For instance, iSenz is an adaptor for smart insulin pens that possess a feature to detect the insulin level, by scanning. It provides the correct angles for injections in order to optimize the injection sites for diabetes.
  • For a better understanding of the market adoption of the neoantigen cancer vaccine, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia Pacific is anticipated to grow with significant CAGR during the forecast period, owing to factors, including rising geriatric population and target populations, increasing number of collaborations for the development of biosimilars, geographic expansion of key players, and active participation of government & nonprofit organizations in the market space. For instance, in July 2021, global contract development and manufacturing organization (CDMO), Recipharm, announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity increase to 1 billion sterile units per year. The above-mentioned factors are driving the regional market during the forecast period.
  • Some of the major players operating in the market include Berkshire Sterile Manufacturing, Syntegon Technology, Novocol Pharma, Recipharm AB, SCHOTT Pharma, Vetter, Sever Pharma Solutions, Cytiva, Grand River Aseptic Manufacturing, and Lonza.

Table of Contents

158 Pages
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Fill Finish Cartridge Market
2.2. Research Methodology of the Fill Finish Cartridge Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE FILL FINISH CARTRIDGE MARKET
6 FILL FINISH CARTRIDGE MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY CARTRIDGE SIZE
7.1. Less than 1ml
7.2. 1ml-3ml
7.3. More than 3ml
8 MARKET INSIGHTS BY DRUG TYPE
8.1. Biologics
8.2. Others
9 MARKET INSIGHTS BY INJECTION DEVICES
9.1. Pens
9.2. Autoinjectors
10 MARKET INSIGHTS BY REGION
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.1.3. Rest of North America
10.2. Europe
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Rest of Asia-Pacific
10.4. Rest of World
11 FILL FINISH CARTRIDGE MARKET DYNAMICS
11.1. Market Drivers
11.2. Market Challenges
12 FILL FINISH CARTRIDGE MARKET OPPORTUNITIES
13 FILL FINISH CARTRIDGE MARKET TRENDS
14 DEMAND AND SUPPLY-SIDE ANALYSIS
14.1. Demand Side Analysis
14.2. VALUE CHAIN ANALYSIS
15 COMPETITIVE SCENARIO
15.1. Competitive Landscape
15.1.1. Porters Fiver Forces Analysis
16 COMPANY PROFILED
16.1. Berkshire Sterile Manufacturing
16.2. Syntegon Technology
16.3. Novocol Pharma
16.4. Recipharm AB
16.5. SCHOTT Pharma
16.6. Vetter
16.7. Sever Pharma Solutions
16.8. Cytiva
16.9. Grand River Aseptic Manufacturing
16.10. Lonza
17 DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us